Lyra Therapeutics, Inc. - COM (LYRA)

Historical Portfolio Holders from Q2 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
45.5 M
Holdings value Q1 2024
$283 M
Value change Q1 2024
+$20.6 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
75
Number of buys Q1 2024
51
Number of sells Q1 2024
-19
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
55234L105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 45.5 M $283 M +$20.6 M $6.22 75
2023 Q4 42.4 M $222 M +$30 M $5.24 61
2023 Q3 30.7 M $120 M -$8.08 M $3.91 43
2023 Q2 33.7 M $138 M +$60.9 M $4.11 38
2023 Q1 18.9 M $38.1 M -$236 K $2.01 30
2022 Q4 19 M $59.8 M -$487 K $3.14 33
2022 Q3 19.2 M $96 M -$622 K $5.01 31
2022 Q2 19.3 M $109 M +$80.7 M $5.65 31
2022 Q1 5.02 M $20.2 M -$472 K $4.02 21
2021 Q4 5.05 M $22 M -$3.58 M $4.36 30
2021 Q3 6.67 M $60.8 M -$2.87 M $9.14 34
2021 Q2 6.86 M $55.1 M -$6.26 M $8.03 37
2021 Q1 7.56 M $87.6 M -$11.8 M $11.59 49
2020 Q4 8.6 M $98 M +$10.2 M $11.40 43
2020 Q3 7.66 M $85.7 M +$6.83 M $11.18 39
2020 Q2 7.04 M $79.8 M +$79.8 M $11.34 43